Phosphatidylcholine treatment to induce lipolysis
2005; Wiley; Volume: 4; Issue: 4 Linguagem: Inglês
10.1111/j.1473-2165.2005.00211.x
ISSN1473-2165
Autores Tópico(s)Metabolism and Genetic Disorders
ResumoThe medicine Lipostabil N has been in widespread use in Europe since 2002 by doctors working in the field of esthetics to achieve a reduction in the volume of smaller fat deposits by means of injections into the subcutaneous fatty tissue. The lipases released from the adipocytes by means of phosphatidylcholine produce a local breakdown of fat that is then discharged over the liver and metabolized via beta-oxidation. The medicine has been authorized for intravenous use in the prophylaxis and therapy of fat embolisms and liver diseases.
Referência(s)